Podcasts about MDMA

We're marking Rare Disease Month 2026 by highlighting the powerful story of Shanthi Hegde, a young patient advocate working to transform how bleeding disorders are understood, treated, and supported. This work is fueled by her own arduous journey with two rare bleeding disorders and immune dysregulatory syndrome, and an extended diagnostic odyssey marked by dismissal, underdiagnosis, and structural bias. “I was told many times by many providers that these disorders are not common in Indians and that my bruises were there just because I'm brown.” Admirably, Shanthi pushed past this mistreatment, advocated for her medical needs, and devoted herself to tackling a range of issues confronting rare disease patients from mental health access to affordable drug pricing to research equity. In this remarkable Year of the Zebra conversation with host Lindsey Smith, you'll also learn about: Shanti's work with the Hemophilia Federation of America; How gaps extend beyond treatment to include insurance coverage, provider training, and substance use care; What clinicians can do to improve the work they do with rare disease patients. Join us for a conversation that connects patient voice to system change, and explores what real equity for rare disease communities will require. Mentioned in this episode:Hemophilia Federation of AmericaShanthi's LinkedIn Profile If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Plus, making the mundane sacred, meditating in a cave, and lowering the ego walls. Michael Pollan is the author of ten books, all of which were New York Times bestsellers. His latest book is A World Appears: A Journey Into Consciousness. In this episode we talk about: How to get over yourself How to reduce rumination How to lower the ego's walls How to elevate mundane tasks The value of what Zen practitioners call "don't know mind" How to reclaim your attention from Big Tech (what Michael calls the "colonizers of consciousness") The value of MDMA-assisted therapy Michael's experiences meditating in a cave Related Episodes: Don't Let This Crisis Go To Waste | Roshi Joan Halifax Get the 10% with Dan Harris app here Sign up for Dan's free newsletter here Follow Dan on social: Instagram, TikTok Subscribe to our YouTube Channel To advertise on the show, contact sales@advertisecast.com or visit https://advertising.libsyn.com/10HappierwithDanHarris  

Thursday Headlines: Families of Australian diplomats told to leave Israel and Lebanon, Sydney duo charged over 85-year-old grandfather's kidnapping and murder, RBA governor denies inflation is 'taking off', health and education records of kids to be tracked for social media ban research, ayahuasca flagged as potential therapy for depression and here's what you think about the proposed e-bike laws. Deep Dive: He was one of the world’s most feared drug lords accused of flooding the US with fentanyl and expanding its grip across Mexico. Nemesio Oseguera Cervantes, known as El Mencho, was killed in a US-backed military raid on Sunday, sparking cartel retaliation that saw several Mexican cities thrown into chaos. In this episode of The Briefing, Chris Spyrou speaks with cartel expert Angelica Duran-Martinez about who El Mencho was, whether removing a kingpin changes the drug trade and what this chaos means for Mexico just months out from hosting the FIFA World Cup. Further listening from the headlines: An Australian clinic is 'transforming' lives with MDMA-assisted therapy How MDMA freed Kate from PTSD Follow The Briefing: TikTok: @thebriefingpodInstagram: @thebriefingpodcast YouTube: @TheBriefingPodcastSee omnystudio.com/listener for privacy information.

Plusieurs débats au cœur de l'actualité, les Grandes gueules ont le choix, en débattre ou non : MDMA, ectasy : ces drogues qui inondent la France Les vidéos en intelligence artificielle inondent la toile Ce singe et sa peluche ont ému le monde entier

Watch every episode ad-free & uncensored on Patreon: https://patreon.com/dannyjones Travis Kitchens was a psychedelic research subject for Johns Hopkins University who eventually uncovered a secret plan to revive religion with drugs. Travis is currently a freelance journalist who writes extensively on the history and philosophy of psychedelic research. He lives in Kentucky. SPONSORS https://rag-bone.com - Use code DANNY & get 20% off sitewide. https://takeultra.com - Use code DANNY for 15% off. https://shopify.com/dannyjones - Sign up for your one-dollar-per-month trial & start selling today. https://amentara.com/go/dj - Use code DJ22 for 22% off. https://whiterabbitenergy.com/?ref=DJP - Use code DJP for 20% off EPISODE LINKS https://vegetabletelevision.substack.com https://www.psymposia.com/magazine/a-channel-for-magic-ralph-hoods-mysticism-scale-and-the-occult-roots-of-the-johns-hopkins-psychedelic-research-program https://www.csmonitor.com/Technology/2019/0418/Why-Wendell-Berry-is-still-not-going-to-buy-a-computer FOLLOW DANNY JONES https://www.instagram.com/dannyjones https://twitter.com/jonesdanny OUTLINE 00:00 - Psymposia is sabotaging MDMA research 05:41 - serpent handling cults 09:41 - FDA reason for rejecting MDMA therapy 16:28 - Psychedelics are being weaponized 21:16 - Andrew Callaghan & Nick Shirley 24:30 - The modern journalism landscape 27:50 - The ChatGPT information model 32:17 - Human lifespans are going DOWN 34:59 - Jordan Peterson & John Vervaeke 38:52 - Epstein's interest in the CIA Stargate program 41:22 - Epstein's interview with Steve Bannon 46:29 - The most likely Epstein theory 49:17 - Art forgery & weaponized art 56:37 - Epstein files are confirming the worst conspiracies 01:01:00 - Jeffrey Epstein's brother is worse than him 01:04:01 - Epstein's art exhibit for Roman Polanski 01:05:28 - Noam Chomsky's Epstein connection 01:12:20 - Dark details of Jolly West 01:15:21 - Charles Manson & MKUltra 01:21:42 - Reagan's war on drugs 01:23:03 - Most likely Manson murder theory 01:28:13 - Candace Owen's new Charlie Kirk theory 01:35:13 - Rise of Nick Feuntes 01:39:07 - Trump's plan to sabotage the mid-terms 01:42:33 - Scientology headquarters 01:49:15 - Why Scientologists don't speak out 01:56:53 - Where L. Ron Hubbard escaped to 01:58:03 - How remote viewing works 02:00:49 - Psychedelics & telepathy 02:03:54 - Coming down from DMT 02:07:02 - The need for psychedelic churches 02:09:40 - New plant stronger than DMT 02:10:31 - Changa plant 02:14:00 - Psychedelic drugs of the future 02:14:36 - Ammon Hillman's debate with Luke Gorton 02:18:28 - The apple of knowledge from Adam & Eve 02:21:16 - Why deadly shark attacks are on the rise 02:31:17 - John Lilly's psychedelic NASA research 02:37:55 - Harmony Korine & IDF fundraising 02:44:09 - Florida's donations to Israel 02:49:23 - Museum of Tarot's conspiracy theories 02:55:17 - Bob Lazar 02:57:40 - Danny's theory on UFOs & aliens 02:58:57 - Alex Jones' predictions 03:04:29 - Probability of life beyond earth 03:07:19 - Is there a "creator"? 03:13:11 - Technology vs. evolution 03:15:07 - Graham Hancock & Flint Dibble 03:17:28 - Ancient Egyptian Vases 03:19:13 - Who the ancient Egyptians were 03:20:26 - Tobacco is worse than LSD 03:25:58 - Paganism in Conan the Barbarian 03:27:45 - Oliver Stone's interview with Putin 03:31:57 - The dark tale of Gary Stewart 03:33:40 - The Immortality Con & the psychedelic renaissance 03:41:25 - Why people must be cautious 03:43:05 - The message of psychedelics Learn more about your ad choices. Visit podcastchoices.com/adchoices

Kari reconnected with her birth mother in her 40s and finally began to understand the suffering for which she had no words. This is a story of adoption and reunification, of forgetting and remembering, of finding a truth without words in the wisdom of the body.  Kari's birth mother was able to see something deep in Kari that she had never had words for….and thus began her path toward healing.Support the show! https://www.buzzsprout.com/396871/supportBringing Therapy into Med Management-- An intensive workshop for psych NPs and PAs, June 3-6 2026 in Ft Collinshttps://www.craigheacockmd.com/bringing-therapy-into-med-management/"I Love You, I Hate You, Are You My Mom?"  An intensive experiential workshop exploring transference and countertransference with Dr. H and Dr. Hillary McBride, June 18-20 2026 in Vancouver BChttps://www.craigheacockmd.com/i-love-you-i-hate-you-are-you-my-mom/Elemental Psychedelics Ketamine-Assisted Psychotherapy Traininghttps://www.elementalpsychedelics.com/ketaminetrainingExplore the podcast through themes, domains, formats, and speakers.The BFTA CODEX is a listener-built and curated field guide to every episode.https://bfta-codex.orgBFTA episode recommendations/Podcast pagehttps://www.craigheacockmd.com/podcast-page/Support the show

Twee mensen overlijden na het drinken van grondstoffen voor drugs die in een jeneverfles zijn beland. Die fles werd gewoon gekocht bij de Gall & Gall. Hoe kon dit gebeuren, was dit de eerste keer en wat zegt het over Nederland als drugsland?Gasten: Carola Houtekamer & Esther RosenbergPresentatie: Bram EndedijkRedactie: Iddo HavingaMontage: Michiel van PoelgeestEindredactie: Nina van HattumCoördinatie: Elze van DrielProductie: Rhea StroinkHeb je vragen, suggesties of ideeën over onze journalistiek? Mail dan naar onze redactie via podcast@nrc.nl.Zie het privacybeleid op https://art19.com/privacy en de privacyverklaring van Californië op https://art19.com/privacy#do-not-sell-my-info.

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

Few issues have tested public trust in medicine as deeply as vaccines, and few individuals have influenced that dialogue more than Dr. Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia and a longtime member of the FDA's Vaccine Advisory Committee. In this timely and candid interview with Raise the Line host Lindsey Smith, Dr. Offit points to this year's severe flu season and a resurgence of measles as alarming proof points of how a changing federal perspective on vaccine policy is having a real impact on public health. “You'd like to think you can educate about the importance of vaccines, but I fear at this point the viruses themselves are doing the educating.” In this wide ranging discussion, Dr. Offit also addresses: The rigorous and painstaking process of developing vaccines, based on his experience co-inventing the rotavirus vaccine. Shifting levels of public trust in scientific organizations. Promising innovations in vaccine development. Don't miss this deeply-informed perspective on the interplay of science, policy, and public education, and his encouraging message to young clinicians about managing the current challenges in public health.  Mentioned in this episode: Vaccine Education Center at Children's Hospital of PhiladelphiaPerelman School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

GBL – Partydroge, Sexdroge oder Lebensgefahr?GBL (Gamma-Butyrolacton) wird oft als „Liquid Ecstasy“ bezeichnet – ist aber chemisch etwas anderes als MDMA. Im Körper wird GBL zu GHB umgewandelt und wirkt stark dämpfend auf das zentrale Nervensystem.In diesem Video geht es um:• Wirkung und Wirkungsdauer• Unterschied zwischen GBL und GHB• Überdosierungsrisiko („G-Schlaf“)• Abhängigkeit & Entzug• Mischkonsum mit Alkohol – warum das lebensgefährlich ist• Konsum im Party- und Chemsex-KontextGBL hat eine extrem schmale Grenze zwischen gewünschter Wirkung und Bewusstlosigkeit.Ein paar Milliliter können den Unterschied machen.Ohne Panikmache.Aber auch ohne Verharmlosung.#GBL #GHB #LiquidEcstasy #Drogenaufklärung #Chemsex #Sucht #Überdosis #SaferUse

Please join my mailing list here

Notes and Links to Lillian Li's Work      Lillian Li is the author of the novel Number One Chinese Restaurant, which was an NPR Best Book of 2018, and longlisted for the Women's Prize and the Center for Fiction's First Novel Prize. Her work has been published in the New York Times, Granta, One Story, Bon Appetit, Travel & Leisure, The Guardian, and Jezebel. Originally from the D.C. metro area, she lives in Ann Arbor. Buy Bad Asians   Kirkus Reviews for Bad Asians   Lillian Li's Website     At about 1:30, Lillian talks about her mindset as Pub Day is a day away, and she shares heartening feedback she's received on Bad Asians At about 3:00, Lillian talks about her early relationship with language and literature, including Amy Tan's Joy Luck Club, and coins a great term, a “Borders Kid” At about 4:40, Lillian describes growing up in a Chinese-American and Asian-American community in connection with ideas of representation  At about 6:30, Lillian reflects on “growing pains” with Joy Luck Club and having ambivalent feelings towards the book's lasting impact At about 8:50, Lillian highlights How to Commit a Postcolonial Murder as a standout text she's reading currently  At about 10:10, Lillian highlights Literati Bookstore as a great place to buy her book and interesting tour events coming up At about 12:05, Lillian gives background on starting the book with a map At about 13:10, Lillian talks about North Potomac, MD, and growing up there  At about 14:50, Pete sets the book's exposition through discussion of the Prologue, and Lillian comments on her interest in the experience of those who have gone viral At about 16:30, Grace as the “golden child” is discussed in terms of Lillian's childhood seeing comparison and "competitive friendships” At about 18:10, the two continue to describe the book's opening and main characters  At about 21:40, Lillian describes the original video that Grace recorded that morphs into the foundation for the “Bad Asians” viral video(s) At about 23:00, Lillian responds to Pete's asking about a middle-of-the-book scene with a caring/boundary-overstepping teacher  At about 25:20, Grace and her gilded rich girl life is described  At about 27:20, Lillian and Pete describe the ways in which the friends like Errol and Justin feel “unburdened” and free in filming with Grace, but also how Grace gets some controversial footage At about 28:55, “Going to the Mall on Molly” and its ramifications is discussed At about 30:40, Lillian describes how Vivían's phone call leads to Grace “running away” to LA At about 32:25, Lillian gives background on the plan that the group hatches in collaboration with Carrie Yang At about 35:00, Vivían and Errol and their post-vows life and rave culture are discussed by Lillian; she talks about MDMA as a sort of emotional regulation   At about 36:30, Lillian talks about the scenes in the book as emblematic of the 2008 recession and recovery in Detroit At about 37:20, Lillian riffs on “self-medication,” with regards to an article she read about overdoses in the Asian-American community/rave culture At about 38:40, Errol's dangerous “pranks” are analyzed  At about 40:00, Lillian discusses the “gilded cage” and “success trap” for Grace and her creative pursuits At about 42:10, the two discuss the notoriety that comes with leaked cell phone footage from the New York At about 42:45, Lillian talks about Justin's sexuality and provides background on her research on bisexuality, intimacy and love for his character  At about 46:00, Pete compliments the ending of the book, and Lillian expands on her mindset in ending the book that way        You can now subscribe to the podcast on Apple Podcasts, and leave me a five-star review. You can also ask for the podcast by name using Alexa, and find the pod on Stitcher, Spotify, and on Amazon Music. Follow Pete on IG, where he is @chillsatwillpodcast, or on Twitter, where he is @chillsatwillpo1. You can watch other episodes on YouTube-watch and subscribe to The Chills at Will Podcast Channel. Please subscribe to both the YouTube Channel and the podcast while you're checking out this episode.       Pete is very excited to have one or two podcast episodes per month featured on the website of Chicago Review of Books. The audio will be posted, along with a written interview culled from the audio. His conversation with Jeff Pearlman, a recent guest, is up soon at Chicago Review.     Sign up now for The Chills at Will Podcast Patreon: it can be found at patreon.com/chillsatwillpodcastpeterriehl      Check out the page that describes the benefits of a Patreon membership, including cool swag and bonus episodes. Thanks in advance for supporting Pete's one-man show, DIY podcast and extensive reading, research, editing, and promoting to keep this independent podcast pumping out high-quality content!    This month's Patreon bonus episode features an exploration of formative and transformative writing for children, as Pete surveys wonderful writers on their own influences.    Pete has added a $1 a month tier for “Well-Wishers” and Cheerleaders of the Show.     This is a passion project, a DIY operation, and Pete would love for your help in promoting what he's convinced is a unique and spirited look at an often-ignored art form.    The intro song for The Chills at Will Podcast is “Wind Down” (Instrumental Version), and the other song played on this episode was “Hoops” (Instrumental)” by Matt Weidauer, and both songs are used through ArchesAudio.com.     Please tune in for Episode 325 with Grant Ginder, the author of the novels Let's Not Do That Again, Honestly, We Meant Well, The People We Hate at the Wedding, Driver's Education, and This is How It Starts, a few of which have been made into movies. His latest is So Old, So Young.     The episode airs on February 20, three days after Pub Day for So Old, So Young.     Please go to ceasefiretoday.org, and/or https://act.uscpr.org/a/letaidin to call your congresspeople and demand an end to the forced famine and destruction of Gaza and the Gazan people.     You can also donate at chuffed.org, World Central Kitchen, and so many more, and/or you can contact writer friend Ursula Villarreal-Moura directly or through Pete, as she has direct links with friends in Gaza.

E441 – Inner Voice | A Heartfelt Chat with Dr. Foojan & Dr. Mohammad Nami In this powerful neuroscience and mental health discussion, Dr. Mohammad Nami, Associate Professor at Canadian University Dubai and Clinical Neuroscience Director at BrainHub UAE, joins Dr. Foojan for a heartfelt and in-depth conversation about memory formation, trauma healing, PTSD treatment, EMDR therapy, neuromodulation, psychedelics in psychiatry, and dementia prevention.

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USOne on One Video Call W/George https://tidycal.com/georgepmonty/60-minute-meeting═══════════════════════════════════════════════════════════════════PSYCHEDELIC COMPOUNDS THAT NO ONE HAS MADE BUT I THINK I WOULD LOVE═══════════════════════════════════════════════════════════════════EPISODE 02: Ψ-COLLAPSE(3,4-Methylenedioxy-N-Superposition-Amphetamine)"The compound that makes you all possible versions of yourself at once, then forces you to choose which one survives measurement."═══════════════════════════════════════════════════════════════════

There are conversations that stretch you a little. And then there are conversations that gently but firmly rearrange the furniture in your mind. This week, I sat down with Keith Kurlander and Will Van Derveer—co-founders of the Integrative Psychiatry Institute—to talk about something that's generating a lot of curiosity and, let's be honest, some anxiety: psychedelic-assisted therapy. Before you brace yourself, this isn't a hype session. It's a thoughtful, grounded conversation about trauma, the nervous system, and what happens when traditional therapy isn't enough to reach the deepest layers of pain we carry. We explored how trauma shapes our personalities, how it imprints on the body, and why insight alone often doesn't create lasting change. As someone who cares deeply about the Enneagram and recovery, I found this especially compelling. So much of our personality structure is built around adaptation—strategies that once kept us safe but now quietly run the show. Keith and Will explain how psychedelic-assisted therapy, when done legally and in carefully structured clinical settings, may help people access and heal places that feel otherwise unreachable. We also talk about the risks, the ethics, and the importance of discernment. This isn't about chasing peak experiences. It's about healing what's unfinished. If you've ever felt stuck in patterns that insight alone couldn't untangle… if you've wondered whether deeper healing is possible… this conversation might open a door.           LEARN MORE ABOUT WILL AND KEITH WILL VAN DERVEER, MD, is a leader in the adoption of integrative psychiatry practices to treat mental health issues. He is cofounder of the Integrative Psychiatry Institute and Integrative Psychiatry Centers and cohost of The Higher Practice Podcast for Optimal Mental Health. He has published research on MDMA-assisted psychotherapy. Dr. Van Derveer has published research on MDMA-assisted psychotherapy for PTSD [1] and written book chapters in the fields of ketamine-assisted psychotherapy and other clinical applications of psychedelic compounds. His passion is finding effective relief from psychological suffering using a vast array of the most natural approaches possible. In addition to traditional medical training, He is a meditation instructor and has trained in shamanism, EMDR, somatic experiencing, internal family systems, cognitive behavioral therapy, and hypnosis. KEITH KURLANDER, MA, LPC, is cofounder of the Integrative Psychiatry Institute and Integrative Psychiatry Centers and cohost of The Higher Practice Podcast for Optimal Mental Health. He graduated Naropa University in 2005 with a master's degree in Transpersonal Counseling Psychology, and he has practiced integrative psychotherapy and coaching with individuals, couples and groups for over 15 years. Keith's work as a coach focuses on celebrities, influencers, entrepreneurs, and CEOs who want to make huge changes in their lives, overcome long-standing patterns, and achieve greater levels of fulfillment. Keith specializes in helping individuals achieve optimal mental health and peak potential.   Social Links & Website (for promotional use) Website - Keith Kurlander, MA, LPC Instagram (Keith) | Instagram (Will)LinkedIn (Keith) | LinkedIn (Will) Psychedelic Therapy: A Revolutionary Approach to Restoring Your Mental Health and Reclaiming Your Life (Shambhala; March 31, 2026),   

“I do not believe we should be testing to test. We have to know, is this test going to change management and is it going to make a difference,” says pediatric allergist-immunologist Dr. Zachary Rubin. His knack for providing that sort of straightforward guidance explains why Dr. Rubin has become a trusted voice on allergies, asthma, and vaccines for his millions of followers on social media platforms. It's also why we couldn't ask for a better guide for our discussion on the rise in allergies, asthma, and immune-related conditions in children, and how families can navigate the quickly evolving science and rampant misinformation in the space. On this episode of Raise the Line, we also preview Dr. Rubin's new book, All About Allergies, in which he breaks down dozens of conditions and diseases, offering clear explanations and practical treatment options for families. Join host Lindsey Smith for this super informative conversation in which Dr. Rubin shares his thoughts on a wide range of topics including: What's behind the rise in allergic and immune-related conditions.Tips for managing misinformation, myths and misunderstandings. How digital platforms can be leveraged to strengthen public health.How to build back public trust in medicine.Mentioned in this episode:All About Allergies bookBench to Bedside PodcastInstagramTikTokYouTube Channel If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this bonus episode, Kim Kaplan, Dr. Jenni Skyler, and Natalie discuss the therapeutic use of psychedelics, particularly MDMA, for healing sexual trauma. They emphasize that different psychedelics are suited to different traumas and that set and setting are crucial. Natalie highlights the importance of a knowledgeable guide and the process of preparation, including obtaining informed consent. They role-play a preparation session, illustrating the need to address ambivalence and fear. Dr. Skyler experiences anxiety and fear, which Natalie validates and respects. The conversation underscores the necessity of creating a safe therapeutic environment where clients can express their true feelings and needs, empowering them in their healing journey.See omnystudio.com/listener for privacy information.

What happens when a 20 year mental health veteran has her own existential crisis then undergoes her own psychedelic therapy? In Inna Zelikman's case, it completely transformed how she practices medicine.Inna Zelikman, RN, MS, ANP, PMH-NP, is the Director of Integrative Mental Health at Recovery Without Walls and a MAPS certified MDMA practitioner. Five years ago, her own psychedelic healing journey changed everything about how she sees and treats patients. Now she's challenging the cookie cutter protocols that dominate our field in favor of what she calls an "organic" approach to treatment.In this conversation, Inna shares her comprehensive patient assessment strategies, the medication categories that secretly block healing (even though they're not contraindications), and why some patients have profound psychedelic experiences but can still struggle.From consulting with psilocybin centers in Oregon to treating ketamine addiction, Inna offers a nuanced perspective on the complexities of psychedelic medicine and why proper preparation, support, and integration actually matter for lasting results.What You'll Learn:

Keywords childhood trauma, MDMA therapy, sexual abuse, repressed memories, family dynamics, forgiveness, healing, survivor stories, therapy, mental health Summary In this conversation, Daniel shares his profound journey of healing from childhood trauma and sexual abuse. He discusses the complexities of uncovering repressed memories, the role of MDMA therapy in his recovery, and the challenges he faced in disclosing his experiences to his family. Daniel emphasizes the importance of understanding grooming and conditioning, the struggle with forgiveness, and the significance of sharing one's story as a means of reclaiming dignity and sovereignty. He also offers valuable insights for therapists working with survivors of trauma, highlighting the need for compassion and understanding in the healing process. Takeaways Daniel's journey began with a struggle against self-hatred and trauma. MDMA therapy played a crucial role in uncovering repressed memories. The process of reliving trauma can be both painful and transformative. Family dynamics can complicate the disclosure of abuse. Grooming and conditioning are key factors in understanding abuse. Forgiveness is a complex and personal journey for survivors. Setting boundaries is essential for healing and self-preservation. Support networks are vital for survivors of trauma. Sharing one's story can be empowering and healing. Therapists should approach survivors with compassion and understanding.   Chapters (timings approx) 00:00 Introduction to Daniel's Journey 01:46 Uncovering Childhood Trauma 05:11 The Role of MDMA Therapy 08:37 The Impact of Repressed Memories 12:25 Family Dynamics and Disclosure 17:33 Understanding Grooming and Conditioning 21:48 The Complexity of Forgiveness 26:13 Advice for Therapists Working with Survivors 30:18 Finding Healing and Support 42:50 The Power of Sharing Your Story

Keywords childhood trauma, MDMA therapy, sexual abuse, repressed memories, family dynamics, forgiveness, healing, survivor stories, therapy, mental health Summary In this conversation, Daniel shares his profound journey of healing from childhood trauma and sexual abuse. He discusses the complexities of uncovering repressed memories, the role of MDMA therapy in his recovery, and the challenges he faced in disclosing his experiences to his family. Daniel emphasizes the importance of understanding grooming and conditioning, the struggle with forgiveness, and the significance of sharing one's story as a means of reclaiming dignity and sovereignty. He also offers valuable insights for therapists working with survivors of trauma, highlighting the need for compassion and understanding in the healing process. Takeaways Daniel's journey began with a struggle against self-hatred and trauma. MDMA therapy played a crucial role in uncovering repressed memories. The process of reliving trauma can be both painful and transformative. Family dynamics can complicate the disclosure of abuse. Grooming and conditioning are key factors in understanding abuse. Forgiveness is a complex and personal journey for survivors. Setting boundaries is essential for healing and self-preservation. Support networks are vital for survivors of trauma. Sharing one's story can be empowering and healing. Therapists should approach survivors with compassion and understanding.   Chapters (timings approx) 00:00 Introduction to Daniel's Journey 01:46 Uncovering Childhood Trauma 05:11 The Role of MDMA Therapy 08:37 The Impact of Repressed Memories 12:25 Family Dynamics and Disclosure 17:33 Understanding Grooming and Conditioning 21:48 The Complexity of Forgiveness 26:13 Advice for Therapists Working with Survivors 30:18 Finding Healing and Support 42:50 The Power of Sharing Your Story

Enamory is a clinical practice, training institute, and nonprofit research organization focused on psychedelic assisted couples therapy. In this episode, clinical psychologists Chandra Kian and Kayla Knopp discuss their work integrating ketamine assisted psychotherapy with evidence based couples therapy models. Both guests trained as academic researchers at the University of California San Diego Veterans Affairs system, where they worked on large scale couples based PTSD trials. They later co founded Enamory to continue clinical work, train therapists, and conduct research focused specifically on relationships. Early Themes in Enamory and Couples Therapy The conversation begins with Dr. Kian and Dr. Knopp describing their background in couples based PTSD research and how that work shaped their clinical approach. They explain how existing couples therapy models often stall when partners cannot soften, access vulnerability, or understand each other's internal experience. Their early exposure to MDMA assisted therapy research highlighted how psychedelic states can temporarily reduce defensiveness and rigid narratives.

What happens when a tech executive building AI infrastructure has a profound spiritual awakening? Pete Sacco went from 368 pounds and type 2 diabetes to complete transformation—discovering that consciousness is eternal while designing the data centers powering the AI revolution. Pete shares his "Commit, Learn, Do" framework, why AI will force humanity to become MORE human, his mystical experiences with plant medicine, and what his 7-year-old daughter taught him about Zen. ABOUT PETE SACCO Pete Sacco is a data center designer, AI infrastructure specialist, author, father of four, and grandfather of three. After a health crisis at age 39, he transformed his life—losing 178 pounds, reversing type 2 diabetes, reconnecting with his estranged son, and experiencing spiritual awakening through plant medicine. Author of "Living in Bliss: Achieve a Balanced Existence of Mind, Body, and Spirit."   KEY TOPICS The "Commit, Learn, Do" framework for total life transformation From 368 pounds and type 2 diabetes to complete remission Why reconnecting with his estranged son was essential to transformation AI and the future: We're at "2 AM" on a 24-hour timeline Plant medicine experiences: MDMA, ketamine, and ayahuasca The ayahuasca vision where he watched himself die Why consciousness is non-local: "We are consciousness observing consciousness" Why AI will make us MORE human, not less What a 7-year-old knows about Zen that adults don't How to find "spacious stillness" in chaos The future of humanity in a post-scarcity world   CONNECT WITH PETE Website: PeteSacco.com Book: "Living in Bliss: Achieve a Balanced Existence of Mind, Body, and Spirit" SUBSCRIBE & REVIEW If this episode resonated with you, please leave a 5-star review and share your biggest takeaway. Your reviews help others discover these conversations! Subscribe to Finding Harmony on Apple Podcasts, Spotify, YouTube, or wherever you listen to podcasts. FIND Harmony online: https://harmonyslater.com/ Harmony on IG: https://www.instagram.com/harmonyslaterofficial/ Finding Harmony Podcast on IG: https://www.instagram.com/findingharmonypodcast/ FREE Manifestation Activation: https://harmonyslater.kit.com/manifestation-activation

Madeline is back to finish up our conversation from last week, and to jump into some new topics. We talk about how education works in neoliberalism, the returning appreciation of learning for learning's sake, objectification in sex work and how feminist can think about navigating that sexwork landscape ethically, cocaine and why it's so hard to get good blow when you're young, the increasing popularity of completely selling out, the way capitalism objectifies nearly everyone who works for a corporation, and lots more, including cocaine injection, MDMA and other drugs. Support the show

In this enlightening episode, host Alex Greene sits down with Dr. Keith Motes, founder of Shaking Medicine and a PhD in quantum physics, to explore the fascinating intersection of science, spirituality, and therapeutic tremoring. Broadcasting from Thailand, Dr. Motes shares his remarkable journey from quantum computing researcher in Australia to becoming a pioneer in teaching neurogenic tremoring. The conversation weaves through multiple lenses—from quantum physics and polyvagal theory to Kundalini yoga, Qigong, and indigenous shamanic practices of the Kalahari Bushmen.Dr. Motes reveals how his initial discovery of spontaneous movement came through a profound plant medicine experience that catalyzed his departure from academia to pursue full-time somatic healing work. Alex and Keith dive deep into the complementary relationship between psychedelic therapy and tremoring practices, discussing how embodied practitioners can better navigate medicine journeys and integrate trauma release. They explore the power of combining bodywork with neurogenic tremoring, emphasizing the importance of practitioners first embodying the work themselves. This episode offers invaluable insights for TRE practitioners, bodyworkers, and anyone interested in the deeper dimensions of somatic healing and nervous system regulation.KEY HIGHLIGHTS:00:01:00 Introducing Dr. Keith Motes00:04:00 Physics to Spiritual Practice00:10:00 First DMT Plant Medicine00:13:00 Discovery of Therapeutic Tremoring00:18:00 Developing Shaking Medicine Practice00:23:00 Indigenous and Shamanic Lenses00:26:00 Kalahari Bushmen Shaking Culture00:29:00 Kundalini and Yoga Perspectives00:33:00 Quantum Physics and Vibration00:40:00 Psychedelics and Tremoring Integration00:47:00 MDMA and Trauma Access00:53:00 Bodywork and Touch Facilitation00:58:00 Sensing Energy and Presence01:03:00 Games and Surrender PhasesRESOURCES MENTIONED:Dr. Bradford Keeney - Work with Kalahari Bushmen: https://www.simonandschuster.com/books/Way-of-the-Bushman/Bradford-Keeney/9781591432050 Shaking Medicine Teacher Training: https://www.shakingmedicine.com/shaking-medicine-teacher-training Zen Shiatsu BodyworkConnect with Dr. Keith Motes:Shaking Medicine website: https://www.shakingmedicine.com Instagram: https://www.instagram.com/shakingmedicine/ Facebook: https://www.facebook.com/shakingmedicinefoundation/   Find us Online:Red Beard Somatic Therapy:Instagram: @redbeardsomatictherapyFacebook: @RedBeardSomaticTherapy

Send us a textPharmacology & neurobiology of psychedelics & MDMA, focusing on isomers, sex-specific effects, and mechanisms in animal models. Not medical advice.TOPICS DISCUSSED:Biased agonism: Different drugs activate the same receptor (e.g., 5-HT2A) but trigger varied intracellular pathways, explaining why LSD is psychedelic while similar lisuride is not.Enantiomers & isomers: Mirror-image versions of drugs like MDMA (S and R forms) and LSD (four isomers) often produce distinct effects; only one LSD isomer is psychedelic, for example.MDMA isomer effects: S-MDMA induces stronger head twitches (psychedelic proxy) via serotonin release, and increases dendritic spines in male mice but not females; R-MDMA has somewhat different effects.Sex-specific drug responses: In mice, females show stronger psychedelic effects (head twitches) from psilocybin and DOI at the same dose, but males exhibit greater post-acute benefits like reduced opioid withdrawal.Psilocybin in opioid addiction models: A single dose reduces place preference for oxycodone and withdrawal symptoms in male mice more than females, with opposite spine density effects in reward-related brain areas.Mechanisms beyond 5-HT2A: Psychedelics involve other receptors like metabotropic glutamate receptors, forming dimers with 5-HT2A to enable dual signaling pathways; effects in subcortical regions like nucleus accumbens are 5-HT2A-independent.Clinical implications: Street MDMA may vary in S/R ratios, affecting experiences; clinical trials often use racemic mixtures without weight-adjusted dosing, potentially missing sex differences.ABOUT THE GUEST: Javier Gonzalez-Maeso, PhD is a professor of pharmacology and toxicology at Virginia Commonwealth University, with a PhD in medicine from Spain focused on G-protein coupled receptors and human brain studies in depression and addiction.RELATED EPISODE:M&M 230 | Psilocybin & MDMA: Inflammation, Stress & Brain-Body Communication | Michael WheelerSupport the showHealth Products by M&M Partners: SporesMD: Premium mushrooms products (gourmet mushrooms, nootropics, research). Use code 'nickjikomes' for 20% off. Lumen device: Optimize your metabolism for weight loss or athletic performance. MINDMATTER gets you 15% off. AquaTru: Water filtration devices that remove microplastics, metals, bacteria, and more from your drinking water. Through link, $100 off AquaTru Carafe, Classic & Under Sink Units; $300 off Freestanding models. Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) For all the ways you can support my efforts

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

This week on the Wrestling Mayhem Show, Sorg, Mad Mike, and Rizz welcome the intergalactic tag team MDMA (El Luca & Los Tonios) for one of the most chaotic, hilarious, and unexpectedly insightful episodes in recent memory. The crew breaks down the latest WWE Royal Rumble, including standout moments from the women's match, mixed reactions to the men's Rumble finish, and how crowd presentation and production choices impacted the overall experience. Along the way, the conversation dives into Saudi Arabia event logistics, roster usage, bonuses, and how WWE continues to evolve its premium live events. MDMA share their origin story, explain what “Most Dope Masked Aliens” really means, talk about landing in 880 Wrestling, and reveal how Rizz mysteriously disappeared with them after the 20 Years of Mayhem celebration. The episode also features the return of Mayhem Mania, where the panel books dream WrestleMania matches under strict rules — and chaos immediately ensues. As always, the show wraps with “What We Learned”, featuring takes on the Royal Rumble, fandom, storytelling, and why wrestling is more fun when you let yourself enjoy the ride.

This week on the Wrestling Mayhem Show, Sorg, Mad Mike, and Rizz welcome the intergalactic tag team MDMA (El Luca & Los Tonios) for one of the most chaotic, hilarious, and unexpectedly insightful episodes in recent memory. The crew breaks down the latest WWE Royal Rumble, including standout moments from the women's match, mixed reactions to the men's Rumble finish, and how crowd presentation and production choices impacted the overall experience. Along the way, the conversation dives into Saudi Arabia event logistics, roster usage, bonuses, and how WWE continues to evolve its premium live events. MDMA share their origin story, explain what “Most Dope Masked Aliens” really means, talk about landing in 880 Wrestling, and reveal how Rizz mysteriously disappeared with them after the 20 Years of Mayhem celebration. The episode also features the return of Mayhem Mania, where the panel books dream WrestleMania matches under strict rules — and chaos immediately ensues. As always, the show wraps with “What We Learned”, featuring takes on the Royal Rumble, fandom, storytelling, and why wrestling is more fun when you let yourself enjoy the ride.

This week on the Wrestling Mayhem Show, Sorg, Mad Mike, and Rizz welcome the intergalactic tag team MDMA (El Luca & Los Tonios) for one of the most chaotic, hilarious, and unexpectedly insightful episodes in recent memory. The crew breaks down the latest WWE Royal Rumble, including standout moments from the women's match, mixed reactions to the men's Rumble finish, and how crowd presentation and production choices impacted the overall experience. Along the way, the conversation dives into Saudi Arabia event logistics, roster usage, bonuses, and how WWE continues to evolve its premium live events. MDMA share their origin story, explain what “Most Dope Masked Aliens” really means, talk about landing in 880 Wrestling, and reveal how Rizz mysteriously disappeared with them after the 20 Years of Mayhem celebration. The episode also features the return of Mayhem Mania, where the panel books dream WrestleMania matches under strict rules — and chaos immediately ensues. As always, the show wraps with “What We Learned”, featuring takes on the Royal Rumble, fandom, storytelling, and why wrestling is more fun when you let yourself enjoy the ride.

Kelly sits down with visionary neuroscientist Gül Dölen—who FedExed seven octopuses to her lab and dosed them with MDMA to understand how brains learn—and to explore what happens when you let wonder lead the way. Gül explains that our brains have windows when they're wide open to learning, that those windows known as "critical periods" close—and more importantly, how we might crack them back open. She and Kelly discuss why pure curiosity, the kind with no practical application in sight, has always been the source of our most important discoveries, and why deprivation and mystical joy might be two paths to the same place. Gül makes the case that there's magic everywhere if you're willing to see the physical world as miraculous, and that lasting change comes not from a pill but from what you learn while your mind is open. Note: This episode discusses neuroscience research on psychedelics, including MDMA. All references are to controlled scientific studies, not recreational use. This episode was made possible by a grant from the John Templeton Foundation. To learn more, please visit ⁠www.templeton.org⁠. Recorded at the Aspen Ideas Festival. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Ce mardi 27 janvier, Joël Guerriau, ancien sénateur de 68 ans, est condamné par le tribunal correctionnel de Paris à quatre ans de prison, dont dix-huit mois ferme.L'élu de Loire-Atlantique, qui avait fini par quitter ses fonctions en octobre dernier, est reconnu coupable de détention de stupéfiant, mais surtout d'avoir drogué la députée Sandrine Josso dans l'intention de la violer ou de l'agresser sexuellement. Le tribunal reconnaît que Joël Guerriau a bien servi du champagne coupé à la MDMA à Sandrine Josso. L'ancien parlementaire réfute en invoquant une “erreur” et a fait appel de la décision du tribunal. Retour sur deux jours d'audience avec Louise Colcombet, grand reporter au service police-justice. Écoutez Code source sur toutes les plates-formes audio : Apple Podcast (iPhone, iPad), Amazon Music, Podcast Addict ou Castbox, Deezer, Spotify.Crédits. Direction de la rédaction : Pierre Chausse - Rédacteur en chef : Jules Lavie - Reporter : Barbara Gouy - Production : Clémentine Spiler, Thibault Lambert et Anaïs Godard - Réalisation et mixage : Julien Montcouquiol - Musiques : François Clos, Audio Network - Archives : Complément d'enquête (France 2). Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

“Climate change is the biggest health threat of our century, so we need to train clinicians for a future where it will alter disease patterns, the demand on health systems, and how care is delivered,” says Dr. Sandro Demaio, director of the WHO Asia-Pacific Centre for Environment and Health, underscoring the stakes behind the organization's first regionally-focused climate and health strategy. The five-year plan Dr. Demaio is leading aims to help governments in 38 countries with 2.2 billion people manage rising heat, extreme weather, sea-level change, air pollution and food insecurity by adapting health systems, protecting vulnerable populations, and reducing emissions from the healthcare sector itself. In this timely interview with Raise the Line host Michael Carrese, Dr. Demaio draws on his experiences in emergency medicine, global public health, pandemic response and climate policy to argue for an interconnected approach to strengthening systems and preparing a healthcare workforce to meet the heath impacts of growing environmental challenges. This is a great opportunity to learn how climate change is reshaping medicine, public health and the future of care delivery.  Mentioned in this episode: WHO Asia-Pacific Centre for Environment and Health If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Listen without ads at:www.patreon.com/dopeypodcastThis Week on The Wednesday Dose of Dopey!Dave kicks off this Wednesday Dose solo from his dad's house, riffing on nostalgic broke-addict snacks (Little Debbie oatmeal pies as cheap highs) and weird fridge finds, before diving into fan Spotify comments praising last week's emotional Erin Khar episode. He shares wild Miles Davis coke-paranoia excerpts from the autobiography (Ferrari abandonment, trash-room hiding, dealer tricks), and recommending Kind of Blue and In a Silent Way as sick sick records!Then we welcome Sandra Vergara (Selling Sunset star, Sofia Vergara's cousin/sister-figure). Sandra opens up about a traumatic Colombian childhood: brother's murder at age 9, raised by an aunt after her bio-mom's brain damage left her mentally stuck at 12, feeling like a "burden," early glue-sniffing experiment, near-fatal ruptured appendix/septic shock at 16, and constant walking-on-eggshells survival via art, empathy, and never taking abuse personally.In LA from 18, she dabbled in makeup/acting (Fright Night), when she began drinking heavy. Blackouts, self-harm (throwing herself through glass), and suicide ideation. followed. First rehab in Medellín (befriended staff for special treatment → false security). Post-rehab: mushrooms sparked a "psychedelic love" fling, ayahuasca faced childhood trauma head-on, but led to half-assed AA and relapses.COVID alone-time in NYC brought painting growth, but cat Stewie's death (worse than losing family) plunged her into deep  depression. Enter ketamine: started therapeutic (Mindbloom) but escalated to daily K-holes with Oculus VR for near-death/grief escapes, addictive Journey Circle weekends (MDMA/ayahuasca/mushrooms group catharsis without integration), erratic calls to mom, club blackouts, and cousin finding her passed out. Family intervention (Sophia pays, nephew packs her) lands her in trauma-focused Breathe Life rehab.She firmly rejects "California sober" as a trap—psychedelics delayed real surrender for her; true addicts can't substitute one mind-alter for another. Full AA commitment (no more a la carte) + Kabbalah (post-breakup desperation) changed everything: tikkun (soul correction via tough life choices), turning reactive impulses (anger/gossip) into proactive restriction, daily study/meditation for frequency shifts. Ties Kabbalah to quantum physics (observer effect = perception shapes reality, entanglement = we're all connected, certainty in the unknown = surrender).Sandra discusses Selling Sunset challenges (producer manipulation, ego, glamour vs. spiritual presence) and her new neuroscience/IFS/Kabbalah coaching for holistic recovery (mind stories, body regulation, spirit alignment). All that and much more on the brand new episode of that good old dopey show!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Summary In this conversation, Gary Roberts and Ash discuss the profound impact of yoga and alternative healing methods on mental health, particularly for first responders. Ash shares insights on yoga nidra, a deep relaxation practice, and its benefits for stress management and healing. They explore the importance of preparation in healing journeys, the stress response in high-pressure professions, and the spiritual aspects of yoga. Practical advice is given for first responders to incorporate grounding practices into their lives, along with addressing common misconceptions about yoga and meditation.   Takeaways Yoga is often misunderstood as just physical exercise. Yoga nidra is a powerful tool for relaxation and healing. Preparation is crucial for effective healing experiences. The stress response can be detrimental to mental health. Yoga offers a holistic approach to well-being. First responders need grounding practices to manage stress. The yogic path includes ethical and spiritual dimensions. Finding personal peace is essential for healing. Breath work can prepare individuals for deeper experiences. Misconceptions about yoga can hinder its benefits.  Chapters 00:00 Introduction and Background of the Guest 03:53 Yoga as a Healing Modality 08:14 The Role of Yoga Nidra in Mental Health 11:57 Integrating Yoga with Psychedelic Therapy 16:03 The Importance of Preparation in Healing 20:03 Understanding Stress Responses in First Responders 23:48 The Path of Yoga and Self-Discovery 30:03 Practical Steps for Grounding and Relaxation 34:01 Misconceptions About Yoga and Meditation 37:55 Finding Your Personal Path in Healing 43:05 Conclusion and Resources for Further Exploration   How to Get Involved: Gary Roberts is the founder and CEO of Neurovus an AI driven mental health app that learns through personal conversation and your waerables, a company based not only on creating and selling a mobile app but one on a mission to change the landscape of how mental health and addiction are treated. Gary founded a non-profit called Promises Recovery Centers for those who need it and created the first-ever educational training facility for Physicians, Therapists, and Mental Health advocates using innovative therapeutics like psilocybin, Mdma, and LSD. You can learn more about Neurovus or Global Retreats reach out to gary@gooddudesgrow.com or connect with him their site, on LinkedIn, and on Instagram. If you enjoyed this episode, don't forget to visit the show on Apple Podcasts and leave a rating and review! We love hearing from you! — We bring unbiased content educating you about Hemp CBD, Cannabis, and Innovative Therapeutics like Psychedelics. Helping people understand the benefits of Hemp CBD, Cannabis, and Psychedelics, removing the fear of the unknown, dispelling myths, and presenting facts. Are you unsure about Hemp-Derived CBD, Cannabis, and Psychedelics but are interested in learning more about the benefits of this alternative solution to big pharma? We will step out into the unknown to clearly understand what is and isn't possible with Plant-Base Medicine and breakthrough therapies using Psychedelics through success stories about health, business, and more.

Jonathan Robinson is a former psychotherapist and author of 16 books.  He has been a frequent guest on Oprah and CNN, and is well known for his groundbreaking work with MDMA assisted therapy.  He has led over 600 MDMA sessions with people over a 40 year period.  His books about MDMA include "Ecstasy as Medicine" and "Ecstasy for Couples."   SHOWNOTES:

Supreme Court hacking and the end of a Biglaw era. ------ The Biglaw world continues to watch single-tier partnerships slip away with Sullivan & Cromwell joining the income partner trend. Will the industry have any single-tier firms left by the end of the year? Also former Senator and current Hogan Lovells lawyer Kyrsten Sinema tagged with an alienation of affection tort from her former bodyguard's soon-to-be ex-wife. Come for the bad soap opera plot, stay for the MDMA-inspired psychedelic trip allegations. Finally, the Supreme Court got hacked, but federal law enforcement managed, a couple years after the fact, to track down the culprit whose social media handle was "ihackedthegovernment." Cracker jack work all around. Subscribe to Above the Law - Thinking Like a Lawyer: https://play.megaphone.fm/lpff6i7nq9wlb-pkdudwtw Learn more about your ad choices. Visit megaphone.fm/adchoices

In this deeply moving episode of Grief to Growth, Brian Smith is joined by writer and seeker Alexis Lee, author of Pain Is a Portal to Beauty, for a courageous conversation about grief, trauma, and radical self-healing.Alexis shares the moment that changed her life — hearing a voice while walking in the woods that told her her life would have been a tragedy if it ended that day. That message became the beginning of a profound journey into grief she had buried since childhood, including the loss of her mother and generational trauma carried in the body.Together, Brian and Alexis explore what happens when we stop running from pain and instead listen to it.This episode isn't about fixing yourself. It's about remembering who you are beneath the pain.

Buckle up for a high-octane hour of The Other Side of Midnight, where Lionel relentlessly connects the dots between military tech, legal chaos, and global politics. This episode kicks off with a controversial claim that the U.S. used Directed Energy Weapons (DEWs)—specifically lasers and high-power microwaves—to kidnap Venezuelan President Maduro. Lionel breaks down the history of these "Star Wars" weapons, insisting they are military reality, not science fiction. Later, Lionel dives into the legal weeds of the Kirsten Cinema lawsuit, discussing "alienation of affection," MDMA, and Taylor Swift tickets. Learn more about your ad choices. Visit megaphone.fm/adchoices

From claims that the U.S. used "Star Wars" lasers to kidnap Venezuela's President Maduro to debating the legal nuances of alienation of affection involving Taylor Swift tickets and MDMA, no topic is too strange. Lionel argues for a fix to societal chaos, critiques Trump's "deer in the headlights" appointees, and debates callers about the imminent threat of a cultural civil war. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this inaugural roundtable discussion, I dive headfirst into one of the most contentious topics at the intersection of faith and science: psychedelics and Christianity. As a relatively new Christian myself, I've been wrestling with what believers should think about these powerful substances—especially after interviewing guests whose lives were transformed by psychedelic experiences, including detransitioners who credit these substances with helping them see through lies they'd built their lives upon.I've gathered four fascinating voices for this conversation, each bringing unique expertise and perspectives. Louie Locke, a pastor of 26 years from Reno, Nevada, rates himself a one out of ten—firmly opposed to psychedelic use from a Christian perspective. He explains his concerns about entering the "second heaven" or spirit realm through means other than Jesus, warning of spiritual doors that may be opened through such substances.Cameron English, a science journalist and director of biosciences at the American Council on Science and Health, brings skepticism from both scientific and theological angles, noting the poor quality of research and drawing parallels to problematic harm reduction movements.Daniel Elliot, an Air Force veteran and counselor who has conducted research on psilocybin and spiritual wellbeing, offers a cautious middle ground as a five, distinguishing between natural substances like psilocybin and synthetic ones like MDMA.Dr. Liza Lockwood, an emergency medicine physician and medical toxicologist, presents the highest rating at seven, explaining her interest in the therapeutic potential for treating refractory depression while sharing the fascinating history of ergot poisoning from the Salem Witch Trials to the discovery of LSD.Together we explore the Greek concept of pharmakeia, whether psychedelics might be connected to the tree of knowledge of good and evil, what harm reduction really means in practice, and whether Christians should be involved in psychedelic-assisted therapy settings. This is just the first in a series exploring these questions—questions that don't have easy answers but deserve thoughtful Christian engagement.Books mentioned:-Imagine Heaven and Imagine The God of Heaven by John Burke-The Great Divorce by C.S. Lewis---WHERE TO FIND THE GUESTSLouie D Locke is the Lead Pastor of Hillside Church in Reno, Nevada, where he has served for 26 years, and also oversees eight churches across Northern Nevada and Eastern California as an Area Pastor. Married to Joni for 36 years with three adult children and eight grandchildren, Louie's life mission is to help people understand and follow God's plan, guiding them toward spiritual wholeness and mature discipleship grounded in biblical integrity. A lifelong learner with passion for history, theology, and thoughtful discussion, he enjoys exploring complex biblical topics and applying Christian principles to everyday life.- X/Twitter: @scoeyd- Church website: hillside4.orgCameron English is a writer, editor and co-host of the Science Facts and Fallacies Podcast. Before joining ACSH, he was managing editor at the Genetic Literacy Project, a nonprofit committed to aiding the public, media, and policymakers by promoting science literacy.- X/Twitter: @CamJEnglish- Website: acsh.org (American Council on Science and Health)- Podcast: Science Facts and Fallacies (with Dr. Liza Lockwood)Daniel Mark Elliott Jr., LMHCA, is a Protestant psychoanalytic counselor specializing in psychosis, dissociation, and cultural fragmentation. An Air Force veteran, psychedelic researcher, and founded Mad River Counseling. He is currently writing a book titled My Psychosis while developing a framework on how minds form reality, coherence, and meaning in fragmented societies.- X/Twitter: @Olaf_The_Third- Website: mad-river.orgDr. S. Eliza Lockwood is an emergency medicine physician and medical toxicologist who completed her fellowship at NYU in 2006 and went on to establish an ACGME-accredited program at Washington University in St. Louis. Driven by a passion for sustainable global health solutions, she has organized humanitarian relief efforts, founded a global health scholar track, and now serves as Medical Affairs Lead for Bayer, focusing on innovative approaches to malnutrition and disease prevention in developing countries. She lectures nationally and internationally on medical toxicology, tropical medicine, and global health.- X/Twitter: @DrLizaMD- LinkedIn: Liza Lockwood- Podcast: Science Facts and Fallacies (with Cameron English)- Weekly X Space: Thursdays 4-6 PM Central (with Cam and John Entine) discussing science and faith topics[00:00:00] Start[00:00:47] Introduction to Psychedelics and Christianity Roundtable[00:02:30] Rating Scale Explained: One to Ten[00:03:25] Louie Locke Introduction: Pastor, Rating One[00:05:23] Cameron English Introduction: Science Journalist, Rating Two[00:07:13] Daniel Elliot Introduction: Veteran and Counselor, Rating Five[00:08:14] Dr. Liza Lockwood Introduction: Toxicologist, Rating Seven[00:09:16] Why This Topic Matters to Stephanie[00:11:30] Louie Explains His Opposition to Psychedelics[00:19:22] Defining Pharmakeia and Biblical Sorcery[00:25:26] Cam's Journey Through Depression to Faith[00:38:17] Daniel on Natural vs Synthetic Substances[00:55:50] Dr. Liza's Scientific Perspective as a Seven[00:57:22] Salem Witch Trials to LSD: A History[01:10:32] Mid-Episode Break[01:19:45] Defining Harm Reduction and Its Failures[01:35:01] Psychedelics and the Tree of Knowledge[01:47:30] Brian Johnson's Psilocybin and Transhumanism[02:01:06] Seeking God in Mistaken Ways[02:05:20] Final Thoughts from the Panel[02:12:45] Where to Find the GuestsROGD REPAIR Course + Community gives concerned parents instant access to over 120 lessons providing the psychological insights and communication tools you need to get through to your kid. Now featuring 24/7 personalized AI support implementing the tools with RepairBot! Use code SOMETHERAPIST2025 to take 50% off your first month.PODCOURSES: use code SOMETHERAPIST at LisaMustard.com/PodCoursesTALK TO ME: book a meeting.PRODUCTION: Looking for your own podcast producer? Visit PodsByNick.com and mention my podcast for 20% off your initial services.SUPPORT THE SHOW: subscribe, like, comment, & share or donate.Watch NO WAY BACK: The Reality of Gender-Affirming Care. Use code SOMETHERAPIST to take 20% off your order.MUSIC: Thanks to Joey Pe...

Michael Bogenschutz, MD, explains how psychedelic-assisted treatments may offer new options for patients with severe, treatment-refractory psychiatric conditions. He discusses why standard approaches often fall short for complex cases, how psychedelics like psilocybin and MDMA differ from conventional medications, and what careful screening and clinical structure make these treatments safe and effective.Drawing on randomized clinical trials and years of clinical experience, Dr. Bogenschutz describes how psychedelic treatments can produce durable symptom improvement in disorders such as alcohol use disorder and trauma-related conditions. He also explores unresolved scientific questions, including whether the psychedelic experience itself is necessary for therapeutic benefit.Michael Bogenschutz, MD, is Professor of Psychiatry and Director of the Center for Psychedelic Medicine at NYU Langone Health.▶️ Watch Insights on Psychiatry on YouTube00:00 A Remarkable Case: Sustained Sobriety After Psilocybin Treatment00:39 Introducing Dr. Michael Bogenschutz01:04 Why Psychiatry Is Re-Examining Psychedelics02:50 Safety, Screening, and Managing the Psychedelic Experience03:45 Landmark Trial: Psilocybin for Alcohol Use Disorder06:16 How Psychedelics Work: Neuroplasticity vs. Subjective Experience08:53 Can Non-Psychedelic Analogs Deliver the Same Benefits?11:47 MDMA, Fear Reduction, and Emotional Processing13:44 Who Benefits Most? A Composite of Treatment-Refractory Patients15:45 The Future of Psychedelic Psychiatry at NYUThis episode is intended for psychiatrists, mental health clinicians, and others interested in complex and treatment-resistant psychiatric conditions.This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle

Super sweet talk with Anders Beck! Say it with an 'ah-nders' not 'and-ers'. Anders tells us jis whole musical/drug/alcohol story! Nothing left out - including the crazy intervention and playing with phil lesh! May he rest in peace! PLUS sick email from Montana in prison! (thanks Nicole!) An amazing dildo filled voicemail from Daniel G! A nice mention from Steve from New Hampshire and so much more more more!PLUS Ander's beautiful song 'Born Again' performed by Greensky Bluegrass, Anders' bonus dobro playing, Damon's 'Dopey World' and Jake from West Virginia's classic version of 'Good So Bad'ALL THAT and more, more, more on this brand new episode of that good old Dopey Show! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fan Mail: Tell Wendy how you're saying yes to yourself!There are so many fabulous opportunities to say YES to yourself this year! Explore Wendy's bespoke tours in 2026: Edinburgh July 6-10, Paris Christmas Markets December 1-7, and more!Space to Dream Retreats Around the WorldWhat if your next chapter could begin in a beautiful city, with a few quiet hours just for you? Space to Dream is a half-day, in-person workshop experience designed to help you step out of the noise and into a moment of intentional pause. City dates & registration now open.In this episode, Wendy sits down with Alexis Leigh, author of Pain is a Portal to Beauty, who heard a voice on a walk at age 38 that changed everything: "If you die today, your life will have been a tragedy." That moment of brutal honesty—acknowledging she was deeply lonely and deeply sad—opened a path that led Alexis through divorce, psychedelic healing journeys, and the discovery that the hopes and dreams in our hearts aren't foolish. They're pointing to something real. They explore:How psychedelic journeys with MDMA, psilocybin, and ayahuasca helped unlock grief and discover what love actually isWhy the darker healing journeys are sometimes easier to integrate from when you do the hard work with the medicineHow our kids carry our emotions in their bodies, and we carry our parents' emotions in ours, and what to do about itThis is a conversation about leading yourself into painful places to unlock more freedom, discovering you have everything you need within, and learning that everyone's path gets to be right for them. Connect with Alexis:AlexisLeigh.comContact Alexis for a free copy of her book here. Referenced in this Episode: Dr. Sue MorterCalling in the One by Katherine Woodward Thomas________________________________________________________________________________________ Connect with Wendy: LinkedinInstagram: @phineaswrighthouseFacebook: Phineas Wright House Website: Phineas Wright House PWH Farm StaysPWH Curated Experience and Travel Interested in being a guest on the show? Send your pitch to podcast@phineaswrighthouse.com Podcast Production By Shannon Warner of Resonant Collective Want to start your own podcast? Let's chat! If this episode resonated, follow Say YES to Yourself! and leave a 5-star review. It helps more women in midlife discover the tools, stories, and community that make saying YES not only possible, but powerful.

In this Huberman Lab Essentials episode, my guest is Dr. Paul Conti, MD, a psychiatrist and expert in treating trauma and psychiatric illness. We explain what trauma is and how it affects the mind and body, as well as the best treatment approaches to support recovery. We also discuss why guilt and shame often follow traumatic experiences and why processing trauma is essential for healing. Dr. Conti shares practical tools for how to choose and work effectively with a therapist and discusses the therapeutic potential of psychedelics and MDMA in clinician-assisted settings. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman Function Health: https://functionhealth.com/huberman LMNT: https://drinklmnt.com/huberman Timestamps (00:00:00) Paul Conti (00:00:21) What is Trauma?, Guilt & Shame (00:03:20) Evolutionary Context of Trauma, Shame & Guilt (00:07:18) Sponsor: Function (00:08:59) Repetition Compulsion, Repeating Trauma (00:12:48) Processing Trauma in Therapy or On Your Own, Grieving (00:16:48) Introspection, Tool: Processing Trauma Through Words (00:18:04) Sponsor: LMNT (00:19:35) Finding a Therapist, Rapport; Duration of Therapy (00:21:49) Prescriptions, Depression, Treating Core Issues (00:24:28) Psychedelics & Overcoming Trauma, Psychedelic-Assisted Therapy (00:28:18) Sponsor: AGZ by AG1 (00:29:48) MDMA, Overcoming Fear (00:31:43) Talking about Trauma, Language (00:33:36) Taking Care of Oneself, Tool: Self-Care Basics (00:36:56) Acknowledgements Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

This Week on The Wednesday Dose of Dopey!Dave kicks off this Wednesday Dose solo from his dad's house, riffing on nostalgic broke-addict snacks (Little Debbie oatmeal pies as cheap highs) and weird fridge finds, before diving into fan Spotify comments praising last week's emotional Erin Khar episode. He shares wild Miles Davis coke-paranoia excerpts from the autobiography (Ferrari abandonment, trash-room hiding, dealer tricks), and recommending Kind of Blue and In a Silent Way as sick sick records!Then we welcome Sandra Vergara (Selling Sunset star, Sofia Vergara's cousin/sister-figure). Sandra opens up about a traumatic Colombian childhood: brother's murder at age 9, raised by an aunt after her bio-mom's brain damage left her mentally stuck at 12, feeling like a "burden," early glue-sniffing experiment, near-fatal ruptured appendix/septic shock at 16, and constant walking-on-eggshells survival via art, empathy, and never taking abuse personally.In LA from 18, she dabbled in makeup/acting (Fright Night), when she began drinking heavy. Blackouts, self-harm (throwing herself through glass), and suicide ideation. followed. First rehab in Medellín (befriended staff for special treatment → false security). Post-rehab: mushrooms sparked a "psychedelic love" fling, ayahuasca faced childhood trauma head-on, but led to half-assed AA and relapses.COVID alone-time in NYC brought painting growth, but cat Stewie's death (worse than losing family) plunged her into deep  depression. Enter ketamine: started therapeutic (Mindbloom) but escalated to daily K-holes with Oculus VR for near-death/grief escapes, addictive Journey Circle weekends (MDMA/ayahuasca/mushrooms group catharsis without integration), erratic calls to mom, club blackouts, and cousin finding her passed out. Family intervention (Sophia pays, nephew packs her) lands her in trauma-focused Breathe Life rehab.She firmly rejects "California sober" as a trap—psychedelics delayed real surrender for her; true addicts can't substitute one mind-alter for another. Full AA commitment (no more a la carte) + Kabbalah (post-breakup desperation) changed everything: tikkun (soul correction via tough life choices), turning reactive impulses (anger/gossip) into proactive restriction, daily study/meditation for frequency shifts. Ties Kabbalah to quantum physics (observer effect = perception shapes reality, entanglement = we're all connected, certainty in the unknown = surrender).Sandra discusses Selling Sunset challenges (producer manipulation, ego, glamour vs. spiritual presence) and her new neuroscience/IFS/Kabbalah coaching for holistic recovery (mind stories, body regulation, spirit alignment). All that and much more on the brand new episode of that good old dopey show!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We have a special episode of Raise the Line on tap today featuring the debut of host Dr. Parsa Mohri, who will now be leading our NextGen Journeys series that highlights the fresh perspectives of learners and early career healthcare professionals around the world on education, medicine, and the future of care. Parsa was himself a NextGen guest in 2024 as a medical student at Acibadem University in Turkey. He's now a general physician working in the Adult Palliative Care Department at Şişli Etfal Research and Training Hospital in Istanbul.  Luckily for us, he's also continuing in his role as a Regional Lead for the Osmosis Health Leadership Initiative (OHLI). For his first guest, Parsa reached out to a former colleague in the Osmosis family, Negeen Farsio, who worked with him as a member of OHLI's predecessor organization, the Osmosis Medical Education Fellowship. Negeen is now a graduate student in medical anthropology at Brunel University of London, a degree which she hopes will inform her future work as a clinician. “Medical anthropology is a field that looks at healthcare systems and how human culture shapes the way we view different illnesses, diseases, and treatments and helps you to see the full picture of each patient.” You are sure to enjoy this heartfelt conversation on how Negeen's lived experience as a patient and caregiver have shaped her commitment to mental health and patient advocacy, and how she hopes to marry humanity with medicine in a world that yearns to heal. If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Supreme Court hacking and the end of a Biglaw era. ------ The Biglaw world continues to watch single-tier partnerships slip away with Sullivan & Cromwell joining the income partner trend. Will the industry have any single-tier firms left by the end of the year? Also former Senator and current Hogan Lovells lawyer Kyrsten Sinema tagged with an alienation of affection tort from her former bodyguard's soon-to-be ex-wife. Come for the bad soap opera plot, stay for the MDMA-inspired psychedelic trip allegations. Finally, the Supreme Court got hacked, but federal law enforcement managed, a couple years after the fact, to track down the culprit whose social media handle was "ihackedthegovernment." Cracker jack work all around.